MedPage Today -- NEW ORLEANS -- Preclinical experiments indicate that a new phosphodiesterase 4 inhibitor may have potent effects on chronic obstructive pulmonary disease (COPD), Indian researchers reported here.
MedPage Today -- NEW ORLEANS -- Preclinical experiments indicate that a new phosphodiesterase 4 inhibitor may have potent effects on chronic obstructive pulmonary disease (COPD), Indian researchers reported here.
